Oligopeptide compound with HIV-1 protease inhibitory activity, and preparation method and application thereof

The present invention provides an oligopeptide compound with an amino acid sequence of Tyr-Leu-Val-Leu-His (SEQ ID NO:1) and HIV-1 protease inhibitory activity. The oligopeptide compound provided by the invention can be produced from chemical synthesis, or recombination, or microorganism (particular...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: TAO PEIZHEN, SI SHUYI, BAI SHUOKE, WEI YUZHEN, LIU XIAO, JIANG WEI, DONG BIAO, YU LIYAN, JIANG JIANDONG, FAN XIUYONG, ZHANG TIAN
Format: Patent
Sprache:chi ; eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator TAO PEIZHEN
SI SHUYI
BAI SHUOKE
WEI YUZHEN
LIU XIAO
JIANG WEI
DONG BIAO
YU LIYAN
JIANG JIANDONG
FAN XIUYONG
ZHANG TIAN
description The present invention provides an oligopeptide compound with an amino acid sequence of Tyr-Leu-Val-Leu-His (SEQ ID NO:1) and HIV-1 protease inhibitory activity. The oligopeptide compound provided by the invention can be produced from chemical synthesis, or recombination, or microorganism (particularly actinomycetes) extraction. The invention also provides an extract obtained from microorganism (particularly actinomycetes) and having HIV-1 protease inhibitory activity and a preparation method thereof. The extract contains the oligopeptide compound provided by the invention. The invention also provides microorganisms (particularly actinomycetes, such as Actinomyces CGMCC 4766) for obtaining the oligopeptide compound or extract provided by the invention. The oligopeptide compound or extract provided by the invention can be used for prevention and treatment of HIV infection related diseases, such as AIDS.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN102766194A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN102766194A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN102766194A3</originalsourceid><addsrcrecordid>eNqNyrEKwlAMQNEuDqL-Q9wtWJWKoxSlLrqIa4mvqS_QNuE1Kv17Rf0ApwuHO4yaU803UVLjksBJo3JvS3iyecgPlzgBDWKEHQG3nq9sEnpAZ_xg62eA71kDKQY0lhYaMi_lh1G1Zvdl8xRIqnE0qLDuaPLrKJrud-csj0mloE7RUUtWZMdkvlinabJZbZf_PC-GrkJx</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Oligopeptide compound with HIV-1 protease inhibitory activity, and preparation method and application thereof</title><source>esp@cenet</source><creator>TAO PEIZHEN ; SI SHUYI ; BAI SHUOKE ; WEI YUZHEN ; LIU XIAO ; JIANG WEI ; DONG BIAO ; YU LIYAN ; JIANG JIANDONG ; FAN XIUYONG ; ZHANG TIAN</creator><creatorcontrib>TAO PEIZHEN ; SI SHUYI ; BAI SHUOKE ; WEI YUZHEN ; LIU XIAO ; JIANG WEI ; DONG BIAO ; YU LIYAN ; JIANG JIANDONG ; FAN XIUYONG ; ZHANG TIAN</creatorcontrib><description>The present invention provides an oligopeptide compound with an amino acid sequence of Tyr-Leu-Val-Leu-His (SEQ ID NO:1) and HIV-1 protease inhibitory activity. The oligopeptide compound provided by the invention can be produced from chemical synthesis, or recombination, or microorganism (particularly actinomycetes) extraction. The invention also provides an extract obtained from microorganism (particularly actinomycetes) and having HIV-1 protease inhibitory activity and a preparation method thereof. The extract contains the oligopeptide compound provided by the invention. The invention also provides microorganisms (particularly actinomycetes, such as Actinomyces CGMCC 4766) for obtaining the oligopeptide compound or extract provided by the invention. The oligopeptide compound or extract provided by the invention can be used for prevention and treatment of HIV infection related diseases, such as AIDS.</description><language>chi ; eng</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROCESSES USING MICROORGANISMS ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2012</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20121107&amp;DB=EPODOC&amp;CC=CN&amp;NR=102766194A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20121107&amp;DB=EPODOC&amp;CC=CN&amp;NR=102766194A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>TAO PEIZHEN</creatorcontrib><creatorcontrib>SI SHUYI</creatorcontrib><creatorcontrib>BAI SHUOKE</creatorcontrib><creatorcontrib>WEI YUZHEN</creatorcontrib><creatorcontrib>LIU XIAO</creatorcontrib><creatorcontrib>JIANG WEI</creatorcontrib><creatorcontrib>DONG BIAO</creatorcontrib><creatorcontrib>YU LIYAN</creatorcontrib><creatorcontrib>JIANG JIANDONG</creatorcontrib><creatorcontrib>FAN XIUYONG</creatorcontrib><creatorcontrib>ZHANG TIAN</creatorcontrib><title>Oligopeptide compound with HIV-1 protease inhibitory activity, and preparation method and application thereof</title><description>The present invention provides an oligopeptide compound with an amino acid sequence of Tyr-Leu-Val-Leu-His (SEQ ID NO:1) and HIV-1 protease inhibitory activity. The oligopeptide compound provided by the invention can be produced from chemical synthesis, or recombination, or microorganism (particularly actinomycetes) extraction. The invention also provides an extract obtained from microorganism (particularly actinomycetes) and having HIV-1 protease inhibitory activity and a preparation method thereof. The extract contains the oligopeptide compound provided by the invention. The invention also provides microorganisms (particularly actinomycetes, such as Actinomyces CGMCC 4766) for obtaining the oligopeptide compound or extract provided by the invention. The oligopeptide compound or extract provided by the invention can be used for prevention and treatment of HIV infection related diseases, such as AIDS.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROCESSES USING MICROORGANISMS</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2012</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyrEKwlAMQNEuDqL-Q9wtWJWKoxSlLrqIa4mvqS_QNuE1Kv17Rf0ApwuHO4yaU803UVLjksBJo3JvS3iyecgPlzgBDWKEHQG3nq9sEnpAZ_xg62eA71kDKQY0lhYaMi_lh1G1Zvdl8xRIqnE0qLDuaPLrKJrud-csj0mloE7RUUtWZMdkvlinabJZbZf_PC-GrkJx</recordid><startdate>20121107</startdate><enddate>20121107</enddate><creator>TAO PEIZHEN</creator><creator>SI SHUYI</creator><creator>BAI SHUOKE</creator><creator>WEI YUZHEN</creator><creator>LIU XIAO</creator><creator>JIANG WEI</creator><creator>DONG BIAO</creator><creator>YU LIYAN</creator><creator>JIANG JIANDONG</creator><creator>FAN XIUYONG</creator><creator>ZHANG TIAN</creator><scope>EVB</scope></search><sort><creationdate>20121107</creationdate><title>Oligopeptide compound with HIV-1 protease inhibitory activity, and preparation method and application thereof</title><author>TAO PEIZHEN ; SI SHUYI ; BAI SHUOKE ; WEI YUZHEN ; LIU XIAO ; JIANG WEI ; DONG BIAO ; YU LIYAN ; JIANG JIANDONG ; FAN XIUYONG ; ZHANG TIAN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN102766194A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2012</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROCESSES USING MICROORGANISMS</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>TAO PEIZHEN</creatorcontrib><creatorcontrib>SI SHUYI</creatorcontrib><creatorcontrib>BAI SHUOKE</creatorcontrib><creatorcontrib>WEI YUZHEN</creatorcontrib><creatorcontrib>LIU XIAO</creatorcontrib><creatorcontrib>JIANG WEI</creatorcontrib><creatorcontrib>DONG BIAO</creatorcontrib><creatorcontrib>YU LIYAN</creatorcontrib><creatorcontrib>JIANG JIANDONG</creatorcontrib><creatorcontrib>FAN XIUYONG</creatorcontrib><creatorcontrib>ZHANG TIAN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>TAO PEIZHEN</au><au>SI SHUYI</au><au>BAI SHUOKE</au><au>WEI YUZHEN</au><au>LIU XIAO</au><au>JIANG WEI</au><au>DONG BIAO</au><au>YU LIYAN</au><au>JIANG JIANDONG</au><au>FAN XIUYONG</au><au>ZHANG TIAN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Oligopeptide compound with HIV-1 protease inhibitory activity, and preparation method and application thereof</title><date>2012-11-07</date><risdate>2012</risdate><abstract>The present invention provides an oligopeptide compound with an amino acid sequence of Tyr-Leu-Val-Leu-His (SEQ ID NO:1) and HIV-1 protease inhibitory activity. The oligopeptide compound provided by the invention can be produced from chemical synthesis, or recombination, or microorganism (particularly actinomycetes) extraction. The invention also provides an extract obtained from microorganism (particularly actinomycetes) and having HIV-1 protease inhibitory activity and a preparation method thereof. The extract contains the oligopeptide compound provided by the invention. The invention also provides microorganisms (particularly actinomycetes, such as Actinomyces CGMCC 4766) for obtaining the oligopeptide compound or extract provided by the invention. The oligopeptide compound or extract provided by the invention can be used for prevention and treatment of HIV infection related diseases, such as AIDS.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language chi ; eng
recordid cdi_epo_espacenet_CN102766194A
source esp@cenet
subjects BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROCESSES USING MICROORGANISMS
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
title Oligopeptide compound with HIV-1 protease inhibitory activity, and preparation method and application thereof
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T03%3A12%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=TAO%20PEIZHEN&rft.date=2012-11-07&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN102766194A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true